Senior Cardiologist

Clario, a part of Thermo Fisher Scientific, is a leading provider of endpoint technology solutions for clinical trials. We are seeking a Senior Cardiologist to provide scientific and medical leadership across cardiac safety, cardiac efficacy, and digital physiology solutions. In this highly visible role, you will partner with pharmaceutical sponsors, contribute to regulatory strategy, advance innovative endpoint development, and serve as a trusted cardiology expert internally and externally. Your expertise will help drive high-quality clinical research, support regulatory decision-making, and accelerate the development of therapies that improve patients' lives worldwide. What We Offer Competitive compensation aligned to the Canadian market Comprehensive health, retirement, and wellness benefits Opportunities to work on global, high‑impact clinical programs Collaboration with leading scientists, clinicians, and technologists Ongoing professional development and research engagement What You’ll Be Doing Represent Clario by providing cardiology expertise to pharmaceutical sponsors across consulting services, including protocol design and development, cardiac safety and efficacy strategies, statistical analysis plans, expert report writing, and regulatory representation Serve as a cardiology liaison across internal departments, supporting cardiologist activities, cardiac solutions, safety consulting, and cardiac‑related compliance strategies Support clinical consulting for Digital Physiology and other Clario endpoints, enabling cross‑business‑unit opportunities and therapeutic area strategies Participate in client discussions for prospective and ongoing studies requiring cardiac safety or efficacy approaches Assist Cardiac Solutions Scientific and Medical Affairs leadership in developing, maintaining, and updating policies, procedures, and SOPs, including Cardiology Review Guidelines and expanded digital physiology endpoints Stay current on scientific advancements in cardiac safety and efficacy and educate internal stakeholders as appropriate Support generation of endpoint data through interpretation of ECGs, Holters, patch devices, stress tests, blood pressure variability assessments, and related endpoints, including QA and QC activities Contribute to ECG core lab procedures to enhance interpretation quality, consistency, and operational efficiency Provide sales support by contributing scientific and clinical expertise as needed Support system development and validation efforts for EXPERT and other Clario platforms Participate in meetings and research collaborations with regulatory authorities Provide leadership in statistical innovation and research, supporting sponsor interactions involving statistical design and analysis and contributing strategically across Clario lines of business. What We Look For MD degree required ABIM Board Certification in Cardiovascular Disease required. Canada-based candidates with active U.S. board certification are encouraged to apply. Clinical Cardiac Electrophysiology training preferred Minimum of three years’ experience in the pharmaceutical industry as an employed cardiologist or consultant, particularly in early‑phase development Five or more years of clinical cardiology and electrocardiography experience preferred Experience with concentration‑effect modeling and strong familiarity with ICH E14 guidance preferred Experience authoring reports for QT waivers and working knowledge of clinical pharmacology desirable Prior experience working with or consulting for pharmaceutical sponsors Demonstrated high ethical standards and commitment to representing Clario with integrity and professionalism. At Clario, a part of Thermo Fisher Scientific, our purpose is to transform lives by unlocking better evidence. It’s a cause that unites and inspires us. It’s why we come to work—and how we empower our people to make a positive impact every day. Whether you're advancing clinical science, building innovative technology, or supporting our global teams, your work helps bring life-changing therapies to patients faster.